How it works
Three steps. No fieldwork.
- 01
Drivers
Map what drives benefit-risk in the public record.
- 02
Pulse
Filter signal from noise with patient-expert review.
- 03
Reveal
Structured brief in 3 to 4 weeks.
EfficacyDaily lifeSide effectsDuration
What you walk away with
How patients actually weigh benefit and risk
Not a score. A structured view of which factors matter, to whom, and in what direction. Enough to scope your next research step with confidence.
Start smarter
Ground primary research in real patient experience.
Reduce research risk
Avoid asking the wrong questions in expensive fieldwork.
Hear voices you'd miss
Surface perspectives that don't appear in standard recruitment.
Frequently asked questions
What is RiskReveal?
A patient benefit-risk insight service that surfaces what patients, caregivers, and the published evidence base are saying about a treatment, disease, or product. Human-curated by patient experts, AI-assisted at the sourcing layer. The output is a structured brief that grounds your next research step.
What sources does RiskReveal draw on?
Public patient communities (forums, social, advocacy content), published clinical evidence, and patient-expert curation that filters signal from noise. We blend lived-experience signal with clinical-evidence context, not just social listening.
How is RiskReveal different from desk research?
Desk research summarises what has been published. RiskReveal surfaces what patients are actually saying right now, including voices that do not appear in published literature or standard recruitment, and a patient expert reviews and contextualises the output.
When should I use RiskReveal in a research programme?
Before primary research. RiskReveal grounds your discussion guide in real patient perspective, helps you avoid asking the wrong questions, and surfaces hard-to-reach voices early. It is a lead-in, not a substitute for primary work.
What do I get from a RiskReveal brief?
A structured brief covering: benefit-risk perception by patient segment, treatment-choice drivers, disease-management priorities, hard-to-reach voice surfacing, and recommendations on what to test in primary research.
Book a Consultation to scope your RiskReveal.
A short call to frame the population, the decision, and whether RiskReveal fits as a Lab component or a lead-in.
